# A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

Source: https://onco.cc/trials/nct06906471/  
OnCo record `nct06906471` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of AS1986NS in prostate cancer, run by Antelope Surgical Solutions, Inc, active and no longer recruiting.

## Summary

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS is a phase 1/2 interventional study registered as NCT06906471 by Antelope Surgical Solutions, Inc, with 10 participants planned, started 2026-07-01 and due to reach its primary completion in 2026-10-30. Interventions recorded: AS1986NS.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-10-19
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06906471
- Phase: 1/2
- Setting: A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
- Sponsor: Antelope Surgical Solutions, Inc
- Enrolled: 10

## Notes

- Registry status on 19 October 2026: Active, not recruiting (registry record last updated 16 October 2026; primary completion expected 30 October 2026).

## Sources

- ClinicalTrials.gov NCT06906471: https://clinicaltrials.gov/study/NCT06906471

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- targets: [PSMA](https://onco.cc/targets/psma/)
- companies: [Antelope Surgical Solutions](https://onco.cc/companies/antelope-surgical-solutions/)

---
JSON: https://onco.cc/api/v1/entities/nct06906471.json